WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001038366) A NOVEL POLYPEPTIDE - HUMAN YIP44 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/038366 International Application No.: PCT/CN2000/000460
Publication Date: 31.05.2001 International Filing Date: 20.11.2000
Chapter 2 Demand Filed: 20.06.2001
IPC:
A61K 38/00 (2006.01) ,C07K 14/47 (2006.01)
Applicants: MAO, Yumin[CN/CN]; CN (UsOnly)
XIE, Yi[CN/CN]; CN (UsOnly)
BIOROAD GENE DEVELOPMENT LTD. SHANGHAI[CN/CN]; 12F, 3rd Building No. 111 Zhongshan Bei Er Rd Shanghai 200092, CN (AllExceptUS)
Inventors: MAO, Yumin; CN
XIE, Yi; CN
Agent: WATSON & BAND LAW OFFICES; 61 Nanjing Rd (E) 11th Floor Shanghai 200002, CN
Priority Data:
99 1 24060.X22.11.1999CN
Title (EN) A NOVEL POLYPEPTIDE - HUMAN YIP44 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
(FR) NOUVEAU POLYPEPTIDE YIP44 HUMAIN ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract:
(EN) The invention discloses a new kind of polypeptide-human Yip44 and the polynucleotide encoding said polypeptide and a process for producing the polypeptide by recombinant methods. It also discloses the method of applying the polypeptide for the treatment of various kinds of diseases, such as cancer, hemopathy, HIV infection, immune diseases and inflammation. The antagonist of the polypeptide and therapeutic use of the same is also disclosed. In addition, it refers to the use of polynucleotide encoding said Yip44.
(FR) L'invention concerne un nouveau type de polypeptide Yip44 humain et le polynucléotide codant pour ce polypeptide, ainsi qu'une opération destinée à produire ce polypeptide à l'aide de techniques de recombinaison. L'invention concerne également une méthode d'application de ce polypeptide pour le traitement de nombreux types de maladies telles que le cancer, l'hémopathie, l'infection à VIH, les maladies immunitaires et les inflammations. L'invention concerne en outre l'antagoniste de ce polypeptide et son utilisation thérapeutique. Par ailleurs, elle se rapporte à l'utilisation du polynucléotide codant pour Yip44.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)